But the findings by Perry and her team are especially provocative because they may point the way to an effective treatment for autism—something that does not currently exist. For instance, might nicotine or another drug that stimulates the nicotinic receptors possibly help autism patients? Perry thinks so. In fact, she told Psychiatric News, she would like to explore this possibility. The most recently approved drug for Alzheimer’s disease—galantamine—might also be able to counter autism, Whitehouse conjectures. The reason, he said, is that the drug is thought to be capable of influencing the nicotinic receptors (Psychiatric News, April 20).